Barzolvolimab (CDX-0159) Palmoplantar/Genital Psoriasis Clinical Trial
Do you have Psoriasis?
OptiSkin is looking for healthy volunteers to join our paid clinical trials. Eligible volunteers with psoriasis will receive free biologic medication. Volunteer today and help pave the next generation of psoriasis treatments.
Duration
Study length is 60 weeks after enrollment. There are a total of 15 in-person visits required. Participants will be compensated for time and travel.
Study Specifics
For adult patients 18+ who have been diagnosed with psoriasis. Patients must be treated with Barzolvolimab (CDX-0159) therapy once enrolled.
Eligibility
To participate, you MUST have:
- Psoriasis
You will NOT be eligible if:
- you have received Otezla® (apremilast) in the past
- your child is currently enrolled in another clinical trial
Additional inclusion/exclusion criteria will apply.